Quidel Receives FDA Clearance for Solana Assay

October 24, 2017

Quidel received marketing clearance from the FDA for the Solana respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) assay.

The molecular diagnostic test generates results for 12 patient samples in approximately 45 minutes.

The assay uses Quidel’s novel reverse-transcriptase amplification technology. product line to generate test result. The Solana RSV + hMPV assay received CE Mark in August.

View today's stories